📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Amplified therapeutic targets in high-grade serous ovarian carcinoma - a review of the literature with quantitative appraisal. (2023)

First Author: Talbot T

Attributed to: MICA: Molecular imaging of HER2 receptor expression using PET: mechanistic study of the novel [18F]-HER2-Affibody tracer in metastatic breast cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41417-023-00589-z

PubMed Identifier: 36804485

Publication URI: http://europepmc.org/abstract/MED/36804485

Type: Journal Article/Review

Volume: 30

Parent Publication: Cancer gene therapy

Issue: 7

ISSN: 0929-1903